Endoscopic Tri-Modal Imaging to Distinguish Functional Dyspepsia From Reflux Disease

• Status: Completed
• Trial end date: 2018-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Endoscopic Tri-Modal Imaging which combines Narrow-band Imaging(NBI), Autofluorescence Imaging (AFI) and White-light Imaging (WLI) could be used to identify the indistinct changes in the gut caused by reflux disease,either acid reflux or bile reflux, which make it possible to differentiate reflux disease from functional dyspepsia (FD).

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Chinese PLA General Hospital
• Treatments: Omeprazole; Proton Pump Inhibitors

Criteria

Inclusion Criteria:

• symptoms suggestive of GERD or dyspepsia.

• Presence of symptom for longer than 6 month

• Provision of written informed consent

Exclusion Criteria:

• Any known upper GI disease, other than reflux esophagitis

• Active or healing gastroduodenal ulcer (except scars)

• History of esophageal or gastric surgery.

• Clinically significant heart, lung, liver or kidney disease

• Allergy to proton-pump inhibitor

• Pregnancy